First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT)

CUSIP: 33733E203

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
Shares outstanding
11,300,576
Total 13F shares
3,143,605
Share change
-303,837
Total reported value
$540,228,542
Price per share
$171.93
Number of holders
252
Value change
-$50,274,497
Number of buys
83
Number of sells
119

Quarterly Holders Quick Answers

What is CUSIP 33733E203?
CUSIP 33733E203 identifies FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q3 2024

As of 30 Sep 2024, First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by 252 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,143,605 shares. The largest 10 holders included MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, LPL Financial LLC, Royal Bank of Canada, Berger Financial Group, Inc, ENVESTNET ASSET MANAGEMENT INC, Raymond James Financial Services Advisors, Inc., RAYMOND JAMES & ASSOCIATES, and D.A. DAVIDSON & CO.. This page lists 252 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
247
Q3 2024 holders
252
Holder diff
5
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .